Keiji Nishibeppu

发表

Short- and long-term outcomes of laparoscopic distal gastrectomy versus open distal gastrectomy for gastric cancer in overweight patients

H. Sugita, K. Yamashita, S. Sakuramoto, 2022, Surgery Today.

Overexpression of YEATS4 contributes to malignant outcomes in gastric carcinoma.

H. Tsuda, D. Ichikawa, E. Otsuji, 2018, American journal of cancer research.

Impact of the first era of the coronavirus disease 2019 pandemic on gastric cancer patients: a single-institutional analysis in Japan

H. Sugita, K. Yamashita, S. Sakuramoto, 2022, International Journal of Clinical Oncology.

Verification of the Utility of Palliative Radiotherapy for Hemostasis of Gastric Cancer Bleeding: a Case Control Study

H. Sugita, Y. Hirano, T. Hamaguchi, 2021, Journal of Gastrointestinal Cancer.

Overexpression of CTEN relates to tumor malignant potential and poor outcomes of adenocarcinoma of the esophagogastric junction

H. Tsuda, D. Ichikawa, E. Otsuji, 2017, Oncotarget.

Overexpression of PBK/TOPK Contributes to Tumor Development and Poor Outcome of Esophageal Squamous Cell Carcinoma.

H. Tsuda, D. Ichikawa, E. Otsuji, 2016, Anticancer research.

Impact of loss of skeletal muscle mass within 6–12 months after gastrectomy and S1 adjuvant chemotherapy on the survival prognosis of elderly patients with gastric cancer

H. Sugita, K. Yamashita, S. Sakuramoto, 2022, Surgery Today.

C-reactive protein adjusted for body mass index as a predictor of postoperative complications following laparoscopic gastrectomy for gastric cancer

H. Sugita, K. Yamashita, K. Matsui, 2021, Langenbeck's Archives of Surgery.

Prognostic effect of postoperative duration until adjuvant chemotherapy and cumulative S-1 dose in gastric cancer

E. Otsuji, A. Shiozaki, H. Fujiwara, 2020 .

A successful case of a para-aortic lymphocele treated with autologous peripheral blood injection

D. Ichikawa, E. Otsuji, A. Shiozaki, 2017, Radiology case reports.

Low levels of tumour suppressor miR-655 in plasma contribute to lymphatic progression and poor outcomes in oesophageal squamous cell carcinoma

D. Ichikawa, E. Otsuji, A. Shiozaki, 2019, Molecular Cancer.

Low plasma levels of miR-101 are associated with tumor progression in gastric cancer

D. Ichikawa, E. Otsuji, A. Shiozaki, 2017, Oncotarget.

Depleted tumor suppressor miR-107 in plasma relates to tumor progression and is a novel therapeutic target in pancreatic cancer

D. Ichikawa, E. Otsuji, A. Shiozaki, 2017, Scientific Reports.

Short- and long-term outcomes of laparoscopic distal gastrectomy versus open distal gastrectomy for gastric cancer in overweight patients

H. Sugita, K. Yamashita, S. Sakuramoto, 2022, Surgery Today.

Liquid biopsy in patients with hepatocellular carcinoma: Circulating tumor cells and cell-free nucleic acids

D. Ichikawa, E. Otsuji, A. Shiozaki, 2017, World journal of gastroenterology.

Overexpression of ZRF1 is related to tumor malignant potential and a poor outcome of gastric carcinoma

H. Tsuda, D. Ichikawa, E. Otsuji, 2018, Carcinogenesis.

Plasma microRNA profiles: identification of miR-1229-3p as a novel chemoresistant and prognostic biomarker in gastric cancer

E. Otsuji, A. Shiozaki, H. Fujiwara, 2020, Scientific Reports.

Venous invasion as a risk factor for recurrence after gastrectomy followed by chemotherapy for stage III gastric cancer

D. Ichikawa, E. Otsuji, A. Shiozaki, 2018, BMC Cancer.

Cumulative total S-1 dose in adjuvant chemotherapy affects the long-term outcome following curative gastrectomy for gastric cancer.

E. Otsuji, A. Shiozaki, H. Fujiwara, 2021, American journal of cancer research.

Overexpression of EGFR as an Independent Prognostic Factor in Adenocarcinoma of the Esophagogastric Junction.

H. Tsuda, D. Ichikawa, E. Otsuji, 2017, Anticancer research.

TRIM37 contributes to malignant outcomes and CDDP resistance in gastric cancer

H. Tsuda, E. Otsuji, A. Shiozaki, 2021, Journal of Cancer.

[Two cases of chylous ascites after laparoscopic colorectal cancer surgery].

Keiji Nishibeppu, T. Mugitani, M. Takemura, 2013, Gan to kagaku ryoho. Cancer & chemotherapy.

Evaluating prognostic value and stage migration effects using a positive lymph node ratio in adenocarcinoma of the esophagogastric junction

E. Otsuji, A. Shiozaki, H. Fujiwara, 2023, BMC Cancer.

Plasma miR‐1254 as a predictive biomarker of chemosensitivity and a target of nucleic acid therapy in esophageal cancer

E. Otsuji, A. Shiozaki, H. Fujiwara, 2023, Cancer science.

Depleted tumor suppressor miR-107 in plasma relates to tumor progression and is a novel therapeutic target in pancreatic cancer

D. Ichikawa, H. Taniguchi, E. Otsuji, 2017, Scientific Reports.

Obesity paradox as a new insight from postoperative complications in gastric cancer

E. Otsuji, A. Shiozaki, H. Fujiwara, 2023, Scientific Reports.

Clinical impact of postoperative interval until adjuvant chemotherapy following curative gastrectomy for advanced gastric cancer

E. Otsuji, A. Shiozaki, H. Fujiwara, 2021, Journal of Cancer.

Dismal prognosis of elderly gastric cancer patients who underwent gastrectomy with American Society of Anesthesiologists (ASA) 3

H. Sugita, K. Yamashita, S. Sakuramoto, 2022, Langenbeck's Archives of Surgery.

Remnant gastritis in gastric cancer patients causes loss of muscle mass 6 months after gastrectomy: a retrospective cohort study of Helicobacter pylori infection.

H. Sugita, K. Yamashita, S. Sakuramoto, 2023, Surgery today.

Plasma microRNA profiles: identification of miR-1229-3p as a novel chemoresistant and prognostic biomarker in gastric cancer

E. Otsuji, A. Shiozaki, H. Fujiwara, 2020, Scientific Reports.

Clinical Relevance of Proximal Gastrectomy With Double-flap Esophagogastrostomy Reconstruction With Glycemic Profile and Postgastrectomy Syndromes

E. Otsuji, A. Shiozaki, H. Fujiwara, 2023, AntiCancer Research.

A shorter distal resection margin is a surrogate marker of nodal metastasis and poor prognosis in distal gastrectomy for advanced gastric cancer

E. Otsuji, A. Shiozaki, H. Fujiwara, 2023, BMC Cancer.

Low blood level of tumour suppressor miR-5193 as a target of immunotherapy to PD-L1 in gastric cancer.

E. Otsuji, A. Shiozaki, H. Fujiwara, 2023, British journal of cancer.

Urinary microRNA-210-3p as a novel and non-invasive biomarker for the detection of pancreatic cancer, including intraductal papillary mucinous carcinoma

E. Otsuji, A. Shiozaki, S. Komatsu, 2024, BMC cancer.

Risk assessment for pancreatic fistula by intraoperative image analysis of laparoscopic and robotic gastrectomy.

E. Otsuji, A. Shiozaki, H. Fujiwara, 2024, Surgical endoscopy.

Differences of clinical features and outcomes between male and female elderly patients in gastric cancer

E. Otsuji, A. Shiozaki, H. Fujiwara, 2023, Scientific reports.

Impact of hypoglycemia after gastrectomy on Global Leader Initiative on Malnutrition-defined malnutrition: a retrospective study.

E. Otsuji, A. Shiozaki, H. Fujiwara, 2024, Surgery today.